Blood News and Research

RSS

Blood-incompatible infant heart transplants safe, may save more lives

ABO-incompatible heart transplantation (heart transplantation among non-compatible blood groups) can be safely performed in infants a year old or younger, researchers reported at the American Heart Association's Scientific Sessions 2007.

6 Nov 2007

Blood pressure more of a problem in winter

According to the latest research from the U.S. high blood pressure may be more difficult to control in winter.

6 Nov 2007

Bayer Pharmaceuticals agrees to a marketing suspension of Trasylol

The U.S. Food and Drug Administration (FDA) has announced that, at the agency's request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.

5 Nov 2007

Washington Post examines reaction to study tracking HIV's arrival in U.S. from Haiti

The Washington Post on Monday examined reaction to a recent study that found that HIV likely arrived in the U.S. from Haiti about a decade earlier than previously believed (Stein, Washington Post, 11/5).

5 Nov 2007

What's in a name? Labels like 'normal' and 'abnormal' on test results can affect patients' medical decisions

Patients whose physicians place labels on their test results - such as normal or abnormal, positive or negative - are inclined to make different decisions about their health care than those who receive the same results solely in terms of numbers and other quantifiable measures, according to a new study from the University of Michigan Health System and the VA Ann Arbor Healthcare System.

5 Nov 2007

New study demonstrates that mindfulness techniques promote health for diabetes patients

A new study has found that patients with diabetes are routinely taught to manage their disease but will be more successful if also taught how to deal with the fear, sadness and anger that comes from having it.

5 Nov 2007

Stanford researchers start voluntary program to screen athletes for heart problems

Everyone has heard the stories: the fit 20-something who drops dead in the middle of a marathon, the high school football player who, without warning, dies during practice. While rare, the stories of sudden death among young athletes strike fear into the hearts of parents everywhere.

5 Nov 2007

American women at increased risk of silent coronaries

After examining data from government health surveys undertaken in the United States, researchers say more American women are developing a type of artery disease that raises the risk of death from heart disease and stroke.

5 Nov 2007

First systemic therapy for fatal childhood disease - recessive dystrophic epidermolysis bullosa

University of Minnesota Children's Hospital, Fairview physicians have performed the first bone marrow and cord blood transplant to treat recessive dystrophic epidermolysis bullosa (RDEB).

5 Nov 2007

Big question over new blood-clot buster drug Prasugrel

New research has revealed that the drug Prasugrel produced by drug company Eli Lilly increases the risk of serious bleeding when compared to the standard therapy.

5 Nov 2007

Treat all patients with rare lung disease to prevent stroke, say doctors

Treatment should be offered to all people with a particular rare lung condition, regardless of whether or not they show symptoms of it, say researchers and doctors behind a new study published today.

5 Nov 2007

Smaller heart pump bridges time to transplant for more women

A small, implantable device that helps the heart pump blood works equally well for men and women but may benefit twice as many women awaiting transplants, researchers reported at the American Heart Association's Scientific Sessions 2007.

5 Nov 2007

Scientists challenge the underlying scientific premise behind folic acid fortification

Scientists at the Institute of Food Research have highlighted possible consequences of fortifying flour with folic acid due to new evidence of how it is absorbed by the body.

5 Nov 2007

Medical causes of iatrogenic renal disorders

Nephrologists and other health care providers need to be aware of certain medications and diagnostic test preparations that, in some patients, can cause damage to the kidneys, according to a special clinical update being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.

5 Nov 2007

Plasma serotonin levels can correlate with degree of liver insufficiency

Liver cirrhosis is a worldwide disease with an incidence of 5 - 10% and represents a major health problem everywhere. Prognosis depends on the degree of liver damage and etiology of cirrhosis.

5 Nov 2007

Living kidney donors show no increase in their risk of heart attacks

Living kidney donors show no increase in their risk of heart attacks or other cardiovascular events in the years after donation, according to the largest-ever study of the issue, being presented at the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco.

5 Nov 2007

Research confirms Itamar's PAT technology to diagnose early cardiovascular disease

Itamar Medical announced confirmation of PAT technology by several prestigious research groups. In light of scientific confirmation of PAT technology, Itamar Medical will now promote clinical use in the medical community for the prevention of cardiovascular disease.

5 Nov 2007

FDA requests recall of True Man Sexual Energy and Energy Max

The U.S. Food and Drug Administration yesterday requested a recall of True Man Sexual Energy Nutrient Capsules and Energy Max Energy Supplement Men's Formula Capsules, illegal drug products that contain potentially harmful, undeclared ingredients.

5 Nov 2007

Elderly with hypertension less likely to get lifestyle modification advice from doctors

People older than 60 with high blood pressure are less likely than other groups of patients to receive advice from their doctors about lifestyle modifications that can help lower their blood pressure, a study by UNC researchers concludes.

5 Nov 2007

Common blood pressure medications ACEIs and ARBs provide equal control

Two common classes of blood pressure medications – angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – are equally effective at controlling high blood pressure, according to a report released by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services.

5 Nov 2007

Blood News and Research

Blood-incompatible infant heart transplants safe, may save more lives

Blood pressure more of a problem in winter

Bayer Pharmaceuticals agrees to a marketing suspension of Trasylol

Washington Post examines reaction to study tracking HIV's arrival in U.S. from Haiti

What's in a name? Labels like 'normal' and 'abnormal' on test results can affect patients' medical decisions

New study demonstrates that mindfulness techniques promote health for diabetes patients

Stanford researchers start voluntary program to screen athletes for heart problems

American women at increased risk of silent coronaries

First systemic therapy for fatal childhood disease - recessive dystrophic epidermolysis bullosa

Big question over new blood-clot buster drug Prasugrel

Treat all patients with rare lung disease to prevent stroke, say doctors

Smaller heart pump bridges time to transplant for more women

Scientists challenge the underlying scientific premise behind folic acid fortification

Medical causes of iatrogenic renal disorders

Plasma serotonin levels can correlate with degree of liver insufficiency

Living kidney donors show no increase in their risk of heart attacks

Research confirms Itamar's PAT technology to diagnose early cardiovascular disease

FDA requests recall of True Man Sexual Energy and Energy Max

Elderly with hypertension less likely to get lifestyle modification advice from doctors

Common blood pressure medications ACEIs and ARBs provide equal control

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News